Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis

dc.contributor.authorNeumann, Bjoern
dc.contributor.authorFoerster, Sarah
dc.contributor.authorZhao, Chao
dc.contributor.authorBodini, Benedetta
dc.contributor.authorReich, Daniel S.
dc.contributor.authorBergles, Dwight E.
dc.contributor.authorKáradóttir, Ragnhildur Þóra
dc.contributor.authorLubetzki, Catherine
dc.contributor.authorLairson, Luke L.
dc.contributor.authorZalc, Bernard
dc.contributor.authorStankoff, Bruno
dc.contributor.authorFranklin, Robin J.M.
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:37:42Z
dc.date.available2025-11-20T08:37:42Z
dc.date.issued2020-05-07
dc.descriptionThe authors acknowledge the following support: The UK Multiple Sclerosis Society (MS50 to R.T.K., C.Z., and R.J.M.F.), The Adelson Medical Research Foundation (D.S.R., D.E.B., and R.J.M.F.), Intramural Research Program of NINDS/NIH (D.S.R.), European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (771411 to R.T.K.), The Lister Institute (R.T.K.), and a core support grant from the Wellcome and MRC to the Wellcome-Medical Research Council Cambridge Stem Cell Institute (203151/Z/16/Z to R.T.K. and R.J.M.F.). Publisher Copyright: © 2020 Elsevier Inc.en
dc.description.abstractRegenerative medicines that promote remyelination in multiple sclerosis (MS) are making the transition from laboratory to clinical trials. While animal models provide the experimental flexibility to analyze mechanisms of remyelination, here we discuss the challenges in understanding where and how remyelination occurs in MS.en
dc.description.versionPeer revieweden
dc.format.extent3
dc.format.extent554761
dc.format.extent617-619
dc.identifier.citationNeumann, B, Foerster, S, Zhao, C, Bodini, B, Reich, D S, Bergles, D E, Káradóttir, R Þ, Lubetzki, C, Lairson, L L, Zalc, B, Stankoff, B & Franklin, R J M 2020, 'Problems and Pitfalls of Identifying Remyelination in Multiple Sclerosis', Cell Stem Cell, vol. 26, no. 5, pp. 617-619. https://doi.org/10.1016/j.stem.2020.03.017en
dc.identifier.doi10.1016/j.stem.2020.03.017
dc.identifier.issn1934-5909
dc.identifier.other43318775
dc.identifier.other7498963f-1ca4-4bac-8888-cc14294f2fac
dc.identifier.other85084118366
dc.identifier.other32386552
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6576
dc.language.isoen
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/771411
dc.relation.ispartofseriesCell Stem Cell; 26(5)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85084118366en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectMS sjúkdómuren
dc.subjectMolecular Medicineen
dc.subjectGeneticsen
dc.subjectCell Biologyen
dc.titleProblems and Pitfalls of Identifying Remyelination in Multiple Sclerosisen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
1_s2.0_S1934590920301399_main.pdf
Stærð:
541.76 KB
Snið:
Adobe Portable Document Format

Undirflokkur